AB40. Sexual Side Effects of Medical Treatment of BPH

The document discussed the sexual side effects associated with the medical treatment of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). It highlighted that five alpha reductase inhibitors, such as finasteride and dutasteride, were effective for BPH but could lead to sexual side effects like loss of libido, erectile dysfunction, and decreased ejaculatory volume. Additionally, alpha adrenergic blockers, despite their efficacy and low adverse effects, could cause retrograde and diminished ejaculation. The document emphasized that while the prevalence of these side effects was not high, their impact on patients' quality of life was significant and should be considered alongside the treatments' efficacy for BPH/LUTS.